With Eisai, we received a positive opinion from the Committee for Medicinal Products for Human Use, part of the European Medicines Agency, in our treatment for Alzheimer's disease (AD). This represents a significant advancement in our commitment to people living with AD. Read more in our news release: https://lnkd.in/daj5mnAk #News | #AlzheimersDisease
Biogen
Pananaliksik sa Biotechnology
Cambridge, MA 1,045,574 (na) tagasubaybay
Tungkol sa amin
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
- Website
-
http://www.biogen.com
External na link para sa Biogen
- Industriya
- Pananaliksik sa Biotechnology
- Laki ng kompanya
- 5,001 - 10,000 mga empleyado
- Headquarters
- Cambridge, MA
- Uri
- Pampublikong Kompanya
Mga Lokasyon
-
Pangunahin
225 Binney Street
Cambridge, MA 02142, US
-
Landis & Gyr-Strasse 3
Zug, CH 6300, CH
-
P.O. Box 14627
5000 Davis Drive
Research Triangle Park, NC 27709, US
Mga empleyado sa Biogen
-
Bjoern Rosner
Executive Leader | Digital Operations | Biotech | Pharma | Driving product commercialization and digital innovation from conception to deployment…
-
Saleem Hussaini
Business Technology Leader | Life Sciences | @Biogen
-
Frode Hellesnes
-
Stavros Platakis
Global Head Customer Excellence and Operations BBU at Biogen
Mga update
-
Alzheimer’s disease is a progressive neurological illness that impairs thinking and the independence of millions of people worldwide. Click through to read how Normajo has been navigating the complexities of this disease as a caregiver: https://ow.ly/cllY50U71rB #AlzheimersDisease | #NationalFamilyCaregiversMonth
-
Lee Gervitz, our Vice President and Head of North America Medical will be at The Boston Globe’s Future of Medicine event with industry leaders to discuss advancements of Alzheimer’s disease (AD) research and how the healthcare system is evolving to serve people living with AD. Learn more about this event: https://ow.ly/qJOs50U61gN
-
Nicole has always been passionate about her career in rare diseases, yet she never imagined she would be among the caregiver community, following science from an entirely new and devastating perspective. Click through to read how Nicole and her family are navigating their new normal: https://ow.ly/n4PH50U5En8 #ALS | #NationalFamilyCaregiversMonth | #TeamBiogen
-
We’ll be at ACR Convergence 2024 in Washington, D.C., sharing more about our work to advance options for people living with lupus. Join us at booth #3937. Learn more: https://ow.ly/OSav50U5hRX #ACR24 | #Lupus
-
This Veterans Day we honor the individuals who have dedicated their time and energy to preserving our national security. At Biogen, we are committed to supporting colleagues like Peter Mertz, who brings invaluable experience as a veteran to help drive our corporate mission. Watch Peter's story and join us in expressing our gratitude to all veterans and their families for their service and sacrifice. Learn more about how we are committed to building a culture of inclusion and belonging: https://ow.ly/4ohn50U3vVw #VeteransDay | #TeamBiogen
-
Team Biogen took part in the Alzheimer's Association Walk to End Alzheimer's to raise awareness and hear inspiring stories from community members impacted by this disease. These stories of resilience and courage drive our commitment to combat Alzheimer's disease (AD) and continue pushing forward scientific advancements. See how we’re addressing AD through research and innovation: https://ow.ly/3gfL50U35y5 #TeamBiogen | #ENDALZ | #Walk2EndAlz
-
With patient safety as the first priority, we recognize the critical role of pharmacovigilance. During this year´s #MedSafetyWeek, we’re emphasizing the importance of using medicines correctly and reporting adverse events when they occur. Learn more about Med Safety Week 2024: https://ow.ly/xHBf50TZFxP #MedSafetyWeek | #PatientSafety
-
This morning, we reported our Q3 financial results. Learn more here: https://ow.ly/4Uj750TWvR2 #Earnings | #BIIB |#FinancialResults
-
STARTING SOON: Join our Q3 2024 financial results live webcast at 8:30 AM ET. Join here: https://ow.ly/KoA550TVQjb #Earnings | #BIIB | #FinancialResults
Mga Kaugnay na pahina
Kahalintulad na mga pahina
Mag-browse ng mga trabaho
Stock
BIIB
NASDAQ
20 minuto na antala
$164.89
-0.9 (-0.543%)
- Bukas
- 165
- Mababa
- 163.35
- Mataas
- 175.86
Data mula sa Refinitiv
Makita ang higit pang impormasyon saPondo
Huling Round
Post IPO utang$1,500,000,000.00
Mga mamumuhunan
JP Morgan